These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25880749)

  • 1. QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest.
    Singh H; Singh S; Singla D; Agarwal SM; Raghava GP
    Biol Direct; 2015 Mar; 10():10. PubMed ID: 25880749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSAR-based models for designing quinazoline/imidazothiazoles/pyrazolopyrimidines based inhibitors against wild and mutant EGFR.
    Chauhan JS; Dhanda SK; Singla D; ; Agarwal SM; Raghava GP
    PLoS One; 2014; 9(7):e101079. PubMed ID: 24992720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines.
    Singh H; Kumar R; Singh S; Chaudhary K; Gautam A; Raghava GP
    BMC Cancer; 2016 Feb; 16():77. PubMed ID: 26860193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors.
    Asadollahi-Baboli M
    Mol Divers; 2016 Aug; 20(3):729-39. PubMed ID: 27209475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards predictive inhibitor design for the EGFR autophosphorylation activity.
    San Juan AA
    Eur J Med Chem; 2008 Apr; 43(4):781-91. PubMed ID: 17689836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DrugMint: a webserver for predicting and designing of drug-like molecules.
    Dhanda SK; Singla D; Mondal AK; Raghava GP
    Biol Direct; 2013 Nov; 8():28. PubMed ID: 24188205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of EGFR selective 4,6-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library.
    Zhang Q; Liu Y; Gao F; Ding Q; Cho C; Hur W; Jin Y; Uno T; Joazeiro CA; Gray N
    J Am Chem Soc; 2006 Feb; 128(7):2182-3. PubMed ID: 16478150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.
    Smaill JB; Palmer BD; Rewcastle GW; Denny WA; McNamara DJ; Dobrusin EM; Bridges AJ; Zhou H; Showalter HD; Winters RT; Leopold WR; Fry DW; Nelson JM; Slintak V; Elliot WL; Roberts BJ; Vincent PW; Patmore SJ
    J Med Chem; 1999 May; 42(10):1803-15. PubMed ID: 10346932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. QSAR analysis of tyrosine kinase inhibitor using modified ant colony optimization and multiple linear regression.
    Shi WM; Shen Q; Kong W; Ye BX
    Eur J Med Chem; 2007 Jan; 42(1):81-6. PubMed ID: 16996653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of quinazoline and quinoline bearing 2,2,6,6-tetramethylpiperidine-N-oxyl as potential epidermal growth factor receptor(EGFR) tyrosine kinase inhibitors and EPR bio-probe agents.
    Li S; Guo C; Sun X; Li Y; Zhao H; Zhan D; Lan M; Tang Y
    Eur J Med Chem; 2012 Mar; 49():271-8. PubMed ID: 22309911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity.
    Chen KF; Pao KC; Su JC; Chou YC; Liu CY; Chen HJ; Huang JW; Kim I; Shiau CW
    Bioorg Med Chem; 2012 Oct; 20(20):6144-53. PubMed ID: 22980218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule.
    Mishra NK; Agarwal S; Raghava GP
    BMC Pharmacol; 2010 Jul; 10():8. PubMed ID: 20637097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
    Showalter HD; Sercel AD; Leja BM; Wolfangel CD; Ambroso LA; Elliott WL; Fry DW; Kraker AJ; Howard CT; Lu GH; Moore CW; Nelson JM; Roberts BJ; Vincent PW; Denny WA; Thompson AM
    J Med Chem; 1997 Feb; 40(4):413-26. PubMed ID: 9046331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dragon method for finding novel tyrosinase inhibitors: Biosilico identification and experimental in vitro assays.
    Casañola-Martín GM; Marrero-Ponce Y; Khan MT; Ather A; Khan KM; Torrens F; Rotondo R
    Eur J Med Chem; 2007; 42(11-12):1370-81. PubMed ID: 17637486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of new 4-N-substituted 6-aryl-7H-pyrrolo[2,3-d]pyrimidine-4-amines as highly potent EGFR-TK inhibitors with Src-family activity.
    Kaspersen SJ; Han J; Nørsett KG; Rydså L; Kjøbli E; Bugge S; Bjørkøy G; Sundby E; Hoff BH
    Eur J Pharm Sci; 2014 Aug; 59():69-82. PubMed ID: 24769040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
    González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
    J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2D-QSAR and 3D-QSAR Analyses for EGFR Inhibitors.
    Zhao M; Wang L; Zheng L; Zhang M; Qiu C; Zhang Y; Du D; Niu B
    Biomed Res Int; 2017; 2017():4649191. PubMed ID: 28630865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D MI-DRAGON: a new predictor for protein-ligands interactions and theoretic-experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins.
    Prado-Prado F; García-Mera X; Escobar M; Sobarzo-Sánchez E; Yañez M; Riera-Fernandez P; González-Díaz H
    Eur J Med Chem; 2011 Dec; 46(12):5838-51. PubMed ID: 22005185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.